← FDA DRUG APPROVALS

FDA ANDA · ANDA078637

TOPIRAMATE

Sponsor: ACTAVIS TOTOWA

APPLICATION
ANDA078637
TYPE
ANDA
ORIGINAL APPROVAL
2013-02-27
LATEST ACTION
2013-02-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TOPIRAMATEDiscontinued
TOPIRAMATE 200MG · TABLET · ORAL
TOPIRAMATEDiscontinued
TOPIRAMATE 50MG · TABLET · ORAL
TOPIRAMATEDiscontinued
TOPIRAMATE 100MG · TABLET · ORAL
TOPIRAMATEDiscontinued
TOPIRAMATE 25MG · TABLET · ORAL

Approval history

2013-02-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →